Premium Industrial News

Europe Buys Another 100 Million Doses of BioNTech-Pfizer COVID-19 Vaccine

Europe Buys Another 100 Million Doses of BioNTech-Pfizer COVID-19 Vaccine

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 791 Words

GALWAY, IRELAND--January 13, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The European Union (EU) has agreed to purchase an additional 100 million doses of the COVID-19 vaccine COMIRNATY from Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX).

Within this article: Details additional vaccine purchase from BioNTech-Pfizer, potential vaccine candidates, slow EU approval for new vaccines

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now!(All Fields Required)

Subscription Type:

  • Pay-Per-Article - $5.95
  • Annual Premium News Subscription - $365.00
Pricing Help?